Quintiles replaces CMO Cohen with Takeda's medical affairs director
This article was originally published in Scrip
Executive Summary
Quintiles has named the former medical affairs director of Takeda Pharmaceuticals, Dr Jeffrey A Spaeder, as its new chief medical and scientific officer. He succeeds Dr Oren Cohen who now leads Quintiles’s Phase I clinical research business. At Quintiles, Dr Spaeder will provide leadership in the ethical conduct of studies. He will chair Quintiles’s Drug Safety Committee and serve as vice-chair of Quintiles’ Council on Research Ethics. In addition to his work at Takeda, Dr Spaeder has also served as director of alliance management with Abbott Laboratories, where he managed clinical oncology research collaboration with a biotechnology partner.